Daily SPAC Update – October 23, 2024

by | Oct 23, 2024

IRRX, GBBK, MCAG, MSSA SPAC Extension Votes Set. CDAQ Investor Deck. CAPN Separate Trading Begins. FRLA, LATG Votes Delayed Again.

 Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

SPAC DEAL & EXTENSION VOTES SET
IRRX – Integrated Rail & Resources Acquisition Corp * EXTENSION VOTE SET: Nov 12, 2024
GBBK – Global Blockchain Acquisition Corp * EXTENSION VOTE SET: Nov 05, 2024 * trust $11.11
MCAG – Mountain Crest Acquisition Corp V * EXTENSION VOTE SET: Nov 08, 2024 * trust $11.55
MSSA – Metal Sky Star Acquisition Corp * EXTENSION VOTE SET: Nov 12, 2024 * trust $11.63

SPAC DEALS ANNOUNCED
Oct 22 | FSHP – Flag Ship Acquisition Corp * + Great Rich Technologies Limited
Oct 21 | IVCA – Investcorp India Acquisition Corp * + Bigtincan Holdings Limited

NEW SPAC IPOs
Oct 22: ALDF – Aldel Financial Ii Inc. $200M IPO

OTHER SPAC NEWS
CDAQ – COMPASS DIGITAL ACQUISITION CORP * Investor Deck
IVCA – INVESTCORP INDIA ACQUISITION CORP * Merger Agreement
LATG – CHENGHE ACQUISITION I CO * Vote Adjourn
FRLA – FORTUNE RISE ACQUISITION CORP * Vote Postponed

SPAC LIQUIDATIONS
VISION SENSING ACQUISITION CORP. (VSAC)-> Liquidation on Oct 21
Global Technology Acquisition Corp. I (GTAC)-> Liquidation on Oct 18

SEPARATE WARRANTS/RIGHTS
CAPN on Oct 24

YESTERDAY’S TOP SPAC GAINERS
2.28% ~ $ 11.20 | BLEU – bleuacacia ltd (Pre-Deal)
1.90% ~ $ 11.26 | MCAG – Mountain Crest Acquisition Corp. V (Announced)
1.59% ~ $ 11.51 | BRAC – Broad Capital Acquisition Corp (Announced)
1.27% ~ $ 9.90 | FIAC – Focus Impact Acquisition Corp. (Announced)
.77% ~ $ 11.73 | WINV – WinVest Acquisition Corp. (Announced)

YESTERDAY’S TOP SPAC LOSERS
-9.85% ~ $ 11.72 | PWUP – PowerUp Acquisition Corp. (Announced)
-5.21% ~ $ 10.00 | BHAC – Focus Impact BH3 Acquisition Company (Announced)
-1.87% ~ $ 11.00 | GODN – Golden Star Acquisition Corp (Announced)
-.90% ~ $ 10.51 | AFJK – Aimei Health Technology Co., Ltd. (Announced)
-.48% ~ $ 10.44 | QETA – Quetta Acquisition Corporation (Pre-Deal)

Recent Analysis

Daily SPAC Update – April 16, 2025

Denali Capital Extension Approved. Compass Digital and Technology & Telecommunications Extension Votes Today. Pyrophyte Sets Extension Vote. Newhold III Separate Trading.

Daily SPAC Update – April 14, 2025

Ares Acquisition + Kodiak Robotics Deal Announced. More Deal Terminations. Focus Impact BH3 Extends and Auditor Changed. Altenergy and Healthcare AI Extension Votes Set.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.